Home > Insider Trading > Filing (0001209191-14-032429)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178253	Scynexis Inc	SCYX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1603918	Jean-Yves Nothias	C/O Scynexis, Inc., 3501 C Tricenter Boulevard Durham NC 27713		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-07	5,251	$0.20	5,251	No	4	X	Indirect	By FCPR Biotechnology Fund
Common Stock	Acquisiton	2014-05-07	5,251	$0.20	10,502	No	4	X	Indirect	By FCPR Biotechnology Fund
Common Stock	Acquisiton	2014-05-07	25,998	$0.20	36,500	No	4	X	Indirect	By FCPR Biotechnology Fund
Common Stock	Acquisiton	2014-05-07	46,863	$0.00	83,363	No	4	C	Indirect	By FCPR Biotechnology Fund
Common Stock	Acquisiton	2014-05-07	88,796	$0.00	172,159	No	4	C	Indirect	By FCPR Biotechnology Fund
Common Stock	Acquisiton	2014-05-07	42,336	$0.00	214,495	No	4	C	Indirect	By FCPR Biotechnology Fund
Common Stock	Acquisiton	2014-05-07	30,582	$0.00	245,077	No	4	C	Indirect	By FCPR Biotechnology Fund
Common Stock	Acquisiton	2014-05-07	50,000	$10.00	295,077	No	4	P	Indirect	By FCPR Biotechnology Fund

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	By FCPR Biotechnology Fund
No	4	X	Indirect	By FCPR Biotechnology Fund
No	4	X	Indirect	By FCPR Biotechnology Fund
No	4	C	Indirect	By FCPR Biotechnology Fund
No	4	C	Indirect	By FCPR Biotechnology Fund
No	4	C	Indirect	By FCPR Biotechnology Fund
No	4	C	Indirect	By FCPR Biotechnology Fund
No	4	P	Indirect	By FCPR Biotechnology Fund

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (right to buy)	Disposition	2014-05-07	5,251	$0.00	5,251	$0.20
Common Stock	Common Stock Warrant (right to buy)	Disposition	2014-05-07	5,251	$0.00	5,251	$0.20
Common Stock	Common Stock Warrant (right to buy)	Disposition	2014-05-07	25,998	$0.00	25,998	$0.20
Common Stock	Series B Preferred Stock	Disposition	2014-05-07	166,482	$0.00	46,863	$0.00
Common Stock	Series C Preferred Stock	Disposition	2014-05-07	313,996	$0.00	88,796	$0.00
Common Stock	Series D-1 Preferred Stock	Disposition	2014-05-07	863,672	$0.00	42,336	$0.00
Common Stock	Series D-2 Preferred Stock	Disposition	2014-05-07	623,880	$0.00	30,582	$0.00

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2011-12-07	2016-12-06	No	4	X	Indirect
2012-05-15	2017-05-14	No	4	X	Indirect
2013-12-11	2018-12-10	No	4	X	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect
		No	4	C	Indirect

Footnotes

The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Upon closing of the Issuer's initial public offering, each share of Series B Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-3.536 basis, and had no expiration date.
Upon closing of the Issuer's initial public offering, each share of Series C Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-3.536 basis, and had no expiration date.
Upon closing of the Issuer's initial public offering, each share of Series D-1 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date.
Upon closing of the Issuer's initial public offering, each share of Series D-2 Preferred Stock converted automatically into shares of common stock of the Issuer on a 1-for-20.4 basis, and had no expiration date.